Top Markets
Coin of the day
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
Rangering i aksjer #18092
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Aksjekurs
$10.22
Sist synkronisert: 2026-07-31
Markedsverdi
$212.97M
Endring (1 dag)
4.58%
Endring (1 år)
78.08%
Land
CA
Handel Satellos Bioscience Inc. (MSCL)

Kategori

Aksjeprishistorikk for Satellos Bioscience Inc. (MSCL)
Høyeste sluttskurs: $9.26 den 2026-07-01

Laveste sluttskurs: $152.54 den 2008-01-01
Aksjeprishistorikk for Satellos Bioscience Inc. fra 2008 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 29.26%
2025 -20.28%
2024 84.25%
2023 91.27%
2022 -80.10%
2021 2.79%
2020 -11.41%
2019 10.94%
2018 37.66%
2017 -27.41%
2016 41.02%
2015 -8.55%
2014 -90.26%
2013 -52.35%
2012 195.82%
2011 -36.68%
2010 -30.40%
2009 333.63%
2008 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.33 -8.75%
AU
$757.71 6.76%
CH